Obstructive Sleep Apnea in Children

Obstructive sleep apnea (OSA) is a medical condition that occurs when one stops breathing periodically during sleep. The brief pause in breathing is most often due to obstruction within the airway.

Obstructive Sleep Apnea - Image Credit: Alila Medical Media / Shutterstock
Obstructive Sleep Apnea - Image Credit: Alila Medical Media / Shutterstock

Between 1 – 10% of children are believed to be affected by OSA, and those commonly affected are 3 – 6 years of age. A typical patient is one with Down syndrome or another congenital ailment.

A child experiencing an episode of OSA will appear as if she or he is trying to respire, but there is notably no exchange of pulmonary gases.

Some children may waken during the process so that the resulting increase in airway muscle tone can return air entry to normal. Repetitive OSA cycles during the night may have significant impact on the quality of a child’s sleep.

Obstructive Sleep Apnea in Children - Children's Hospital New Orleans

Causes

Enlarged tonsils and lymphoid glands in the upper respiratory tract are the most common causes of OSA in children.

Hypertrophy of the tonsils, which may occur during an infection, may completely block the nasal passage. This blockage makes it extremely difficult or nearly impossible to breathe through the nose.

During sleep, muscle tone decreases, leading to tissues collapsing to some extent, which is responsible for sleep-induced narrowing of the airway. This narrowing is made worse by the presence of enlarged glands.

Other causative OSA factors are craniofacial anomalies, neuromuscular diseases and, though rare, tumorous growths in the upper airway. Obesity may also be a cause, but this is more common in the adult population.

Signs and Symptoms

Children with OSA may have a spectrum of signs and symptoms that are not uniformly seen in all affected patients.

Some common symptoms, however, include breathing through the mouth, snoring loudly, excessive daytime sleepiness and periodic pauses in breathing during sleep.

OSA patients may have social and academic difficulties and they may be more hyperactive during the day than their peers. Moreover, these children may be aggressive or irritable at times.

Children at the age of 5 or older may also experience enuresis, which is involuntary urination while sleeping.

Furthermore, there may be paradoxical movement of the rib-cage, frequent periods of waking up during the sleep cycle, and diaphoresis, or profuse sweating.

Parents will often note the apneic episodes themselves. Children with OSA commonly have a failure to thrive, because, it is hypothesized, the work required to breathe during sleep causes massive caloric expenditure.

Diagnosis and Treatment

A complete medical history is necessary in addition to physical examination as the initial steps to diagnosing OSA. Sleep specialists, otolaryngologists and, if applicable, pulmonologists are consulted.

Overnight sleep tests at a specialized center are conducted to identify the problem during sleep. Other diagnostic tests that may be employed include chest X-rays in order to ascertain if there are problems within the lungs or large airways.

Treating OSA depends largely on the cause. In the case of enlarged tonsils, surgical removal may be recommended. Other candidates for surgery are children with craniofacial abnormalities.

If surgery would not be beneficial or helpful, then continuous positive airway pressure (CPAP), via a mask, can be used to keep the airway open during sleep. Obese children will need to lose weight as part of the management process.

In other instances, as for neurological or other primary causes of sleep apnea, pharmacotherapy, behavioral modification, and education may be required.

Further Reading

Last Updated: Feb 27, 2019

Dr. Damien Jonas Wilson

Written by

Dr. Damien Jonas Wilson

Dr. Damien Jonas Wilson is a medical doctor from St. Martin in the Caribbean. He was awarded his Medical Degree (MD) from the University of Zagreb Teaching Hospital. His training in general medicine and surgery compliments his degree in biomolecular engineering (BASc.Eng.) from Utrecht, the Netherlands. During this degree, he completed a dissertation in the field of oncology at the Harvard Medical School/ Massachusetts General Hospital. Dr. Wilson currently works in the UK as a medical practitioner.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Wilson, Damien Jonas. (2019, February 27). Obstructive Sleep Apnea in Children. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/health/Obstructive-Sleep-Apnea-in-Children.aspx.

  • MLA

    Wilson, Damien Jonas. "Obstructive Sleep Apnea in Children". News-Medical. 21 December 2024. <https://www.news-medical.net/health/Obstructive-Sleep-Apnea-in-Children.aspx>.

  • Chicago

    Wilson, Damien Jonas. "Obstructive Sleep Apnea in Children". News-Medical. https://www.news-medical.net/health/Obstructive-Sleep-Apnea-in-Children.aspx. (accessed December 21, 2024).

  • Harvard

    Wilson, Damien Jonas. 2019. Obstructive Sleep Apnea in Children. News-Medical, viewed 21 December 2024, https://www.news-medical.net/health/Obstructive-Sleep-Apnea-in-Children.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expert explores the expanding applications of GLP1 therapies